Swiss pharma giant to buy San Diego innovator

Swiss pharma giant to buy San Diego innovator

Global pharmaceutical giant Roche has agreed to buy San Diego based Seragon for up to $1.7 billion. More than half of that amount is dependent on meeting development targets. The purchase of the company, which is only a year old, is largely due to its innovative work on breast cancer treatment; a drug that can block estrogen , a major factor in the spread of tumors. Although the drug is at an early stage of testing, a Roche statement acknowledges that it “could one day redefine the standard of care for hormone receptor-positive breast cancer.” Read the full story.